Lynett Capital Partners — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Tamarind Biotamarind.bio in 𝕏Series A · May 2025

Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US

Deniz Kavi(CEO)in Sherry Liu(Founder)inBrooke Lacina(Recruiter)Recruiting Tamarind Bio(Recruiter)Abraham Penuelas(Technical Recruiter)

Co-investorsEight Capital Transpose Platform Management Treeo VC Y Combinator 468 Capital 6 Dimensions Capital +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.